Please join us in welcoming the new board of the EASO Early Career Network. Learn more, connect and engage.
SAVE THE DATES: PHYSICAL ACTIVITY WEBINARS
November 18th and December 2nd, 2021 19.00 CET
Save the Dates!
Exercise training can help support the management of overweight and obesity in adults and can contribute to health benefits beyond “scale victories”. Further to the Exercise Training Supplement published recently in Obesity Reviews, we are pleased to announce an upcoming webinar series held in collaboration with EASO member society U.K. ASO on 18th November and 2 December 2021. The webinar series will explore scientific evidence around the health benefits of exercise training for people living with overweight and obesity. The full programme and webinar registration will be available soon on the EASO website.
EUROPEAN JOURNAL OF INTERNAL MEDICINE CLINICAL INSIGHT: FOCUS ON OBESITY
community focus on obesity; three feature articles on obesity published in September, October and November issues of EJIM.
September features:
- Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study MF Landecho, M Marin-Oto, B Recalde-Zamacona, I Bilbao, Gema Frühbeck
- Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy Dror Dicker,Assim A. Alfadda,Walmir Coutinho,…Paolo Sbraccia,Verónica Vázquez-Velázquez,Ian D. Caterson and
- The 3Ds – Discussion, diagnosis and direction: Elements for effective obesity care by healthcare professionals Assim A. Alfadda,Ian D. Caterson,Walmir Coutinho,…Javier Salvador,Verónica Vázquez-Velázquez,Paolo Sbraccia
SPANISH SOCIETY OF OBESITY CONGRESS 2021
NOVEMBER 17th – 19th, 2021
EASO President Jason Halford, Scientific Advisory Board co-chair Gema Frühbeck and Executive Director Euan Woodward will deliver the keynote presentation: Let’s talk about Obesity and Policy in the Time of COVID-19.
CECON2021: THE 8TH CENTRAL EUROPEAN CONGRESS ON OBESITY
OCTOBER 7th – 8th, 2021
Dr Eszter Halmy and Professor Tamás Forster look forward to welcoming you to the 8th Central European Congress on Obesity. EASO President Jason Halford will speak at this virtual congress.
ITALIAN SOCIETY OF OBESITY NATIONAL CONGRESS
OCTOBER 27th, 28th, 29th, 2021
The Congress will bring together over 500 specialists from across Italy who are working in the field of obesity.
2021 EFAD CONGRESS
OCTOBER 26th – 30th, 2021
Join our colleagues in the dietitian community for this virtual five-day “journey through European Dietetics”
OBESITYWEEK® 2021
NOVEMBER 1st – 5th, 2021
ObesityWeek® is virtual this year, presenting the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art treatment and prevention, and discussion around advocacy and public policy.
ZOOM FORWARD WITH EASO
We look forward to hosting you at our 29th annual congress in Maastricht 4-7 May 2022. This hybrid event will offer both in-person and online participation options. We are pleased to host this meeting jointly with IFSO-EC. Stay tuned for more information, which will be available soon.
NEW EUROPEAN PATIENT GUIDELINES LAUNCHED ON NAFLD
EASO is pleased to share this new set of patient guidelines developed collaboratively across Europe by experts in hepatology and intended for all patients at risk of, or currently living with non-alcoholic fatty liver disease (NAFLD)
TOP WORLD OBESITY DAY AWARDS GO TO WINNERS FROM SIX EUROPEAN COUNTRIES
We are delighted to announce that organisations from six European countries have been named as winners of the European Association for the Study of Obesity (EASO), and European Coalition for People living with Obesity (ECPO) World Obesity Day Europe Awards for 2020 and 2021.
OBESITY DAY EUROPE
MARCH 4th, 2022
Europe comes together in this global event, held annually on March 4 raising awareness and increasing knowledge about obesity and the many other diseases on which it impacts.
THE ABILITY OF FAT TISSUE TO RESPOND TO A BRAIN HORMONE THAT MAKES US WAKEFUL IS LINKED TO METABOLIC HEALTH AND OBESITY
Orexin is a brain hormone that rises in the morning to make us wakeful. A new study shows that higher levels of orexin in the blood during morning hours is linked to better health; levels of orexin tend to decrease with obesity
ACTION TEENS: ADOLESCENTS AND OBESITY
An important new global study has been launched, surveying awareness, care and treatment of adolescents living with obesity, their caregivers, and healthcare professionals.
REDUCING RISK OF CHILDHOOD OBESITY IN THE WAKE OF COVID-19
Colleagues issue a call to action for governments to prioritise child obesity as they implement measures to recover from the pandemic
It is with great sadness that EASO announces the loss of our former society president, Peter Kopelman, a highly regarded educator, and obesity expert, who has died aged 70.
READ THE LATEST EDITION OF OBESITY FACTS, THE EUROPEAN JOURNAL OF OBESITY
Volume 14 issue 4, is available along with online first articles, all open access.
PROTEIN PROJECT
The PROTEIN Project is a research initiative led by a consortium of European public- and private-sector organisations working to promote health and wellbeing. Bringing together experts from across Europe, PROTEIN will develop tools using AI to provide personalised nutrition and physical activity support to people in the EU.
Visit the PROTEIN Project Website
Introducing the PROTEIN Project App – now available to pilot via Google Play!
We are delighted to share an update about development of the PROTEIN Project App. Learn more about PROTEIN, an innovative tool using AI and big data designed with you in mind, supporting personalised nutrition and physical activity.
Download the PROTEIN app on Google Play
TIMESPAN PROJECT
EASO is pleased to support this new 5 year EU funded H2020 initiative. TIMESPAN, led by scientific coordinator Professor Henrik Larsson (Örebro University), includes 17 partners from across academia, industry, and patient advocacy communities, and aims to foster improvement in clinical management of adults living with with ADHD and co-occurring cardiometabolic disease, including obesity.
SWEET PROJECT
SWEET, a European Commission Horizon 2020 funded project, is supported by a consortium of 29 pan-European research, consumer and industry partners, who are in the process of reviewing and developing evidence on long term benefits and potential risks involved in switching over to sweeteners and sweetness enhancers (S&SEs) in the context of public health and safety, obesity, and sustainability.
FOOD CONSUMPTION AND COMPOSITION DATA – DO WE KNOW WHAT SWEETENERS ARE IN FOOD?
SWEET is reviewing evidence of long-term benefits and potential risks involved in switching to S&SEs in the context of public health and safety, obesity, and sustainability.